Pruritus Therapeutics

A Global Strategic Business Report

MCP14270

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

13042

EXECUTIVE POOL

5850

PRICE

1563

EXPERT INPUTS

38

COMPANIES

123

DATA TABLES

192

PAGES

8

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (8283)

63

CXO

418

VICE PRESIDENT

4701

DIRECTOR

2438

MANAGER

663

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Pruritus Therapeutics Market to Reach US$16.3 Billion by 2030

The global market for Pruritus Therapeutics estimated at US$12.5 Billion in the year 2024, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Antihistamines segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 4.3% CAGR

The Pruritus Therapeutics market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Pruritus Therapeutics Market - Key Trends and Drivers Summarized

Alleviating Discomfort: The Expanding Market for Pruritus Therapeutics

Pruritus, commonly known as itching, is a pervasive symptom associated with numerous dermatological, systemic, and neurological disorders, significantly impacting the quality of life of millions worldwide. Conditions such as atopic dermatitis, psoriasis, chronic kidney disease, and liver disease are often accompanied by persistent and severe pruritus, necessitating effective therapeutic interventions. The growing prevalence of these conditions, coupled with an aging population that is more susceptible to chronic diseases, has led to an increased demand for advanced pruritus therapeutics. This market encompasses a wide range of treatments, including topical corticosteroids, antihistamines, immunomodulators, and novel biologics that target the underlying mechanisms of pruritus. The unmet need for effective and long-lasting relief from itching has driven significant research and development efforts aimed at discovering new therapeutic options.

How Are Technological and Pharmaceutical Innovations Influencing the Market?

Technological and pharmaceutical innovations are playing a pivotal role in advancing pruritus therapeutics. The development of biologics and small-molecule inhibitors that target specific pathways involved in the sensation of itching represents a significant breakthrough in this field. These advanced therapies, such as IL-4 and IL-13 inhibitors for atopic dermatitis and kappa-opioid receptor agonists, offer targeted relief by modulating the immune response or neurological pathways associated with pruritus. Additionally, the use of transdermal delivery systems and novel formulation technologies has improved the efficacy and patient adherence to topical treatments. Furthermore, advancements in diagnostic tools and biomarkers are enabling more precise identification of the underlying causes of pruritus, allowing for more personalized treatment approaches. These innovations are transforming the landscape of pruritus therapeutics, offering hope to patients who suffer from chronic and refractory itching.

What Role Do End-User Segments Play in the Adoption of Pruritus Therapeutics?

The adoption of pruritus therapeutics varies across different end-user segments, including hospitals, dermatology clinics, and home care settings. Hospitals and specialized clinics are the primary centers for the administration of advanced biologics and other systemic treatments for severe cases of pruritus, particularly in patients with complex underlying conditions such as chronic kidney disease or cancer. Dermatology clinics, on the other hand, are more focused on managing pruritus associated with skin disorders, using a combination of topical treatments and patient education to manage symptoms. Home care settings are increasingly adopting over-the-counter antihistamines and topical corticosteroids for mild to moderate pruritus, driven by the convenience and ease of access to these treatments. The rise of telemedicine and remote consultations is also facilitating the management of pruritus in home care settings, allowing patients to receive personalized treatment recommendations without the need for frequent clinic visits.

What Are the Key Growth Drivers in the Market?

The growth in the pruritus therapeutics market is driven by several factors. The increasing prevalence of dermatological and systemic conditions that cause chronic itching, such as atopic dermatitis and chronic kidney disease, is a major driver. Technological advancements in drug development, particularly the emergence of biologics and targeted therapies, have significantly expanded treatment options for pruritus, especially in cases that are refractory to traditional treatments. The growing adoption of personalized medicine, supported by advancements in diagnostics and biomarkers, is also driving the market, as treatments can be tailored to the specific needs of individual patients. Additionally, the expansion of telemedicine and the availability of over-the-counter treatments are making pruritus therapeutics more accessible to a broader population, further supporting market growth. As awareness of the impact of chronic pruritus on quality of life increases, the demand for effective and innovative therapies is expected to continue to rise.

SCOPE OF STUDY

The report analyzes the Pruritus Therapeutics market by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics, Other Products).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Abbott Laboratories; Allergan PLC; Almirall SA; Astellas Pharma, Inc.; Bristol-Myers Squibb Company; Cipla Ltd.; Eisai Co., Ltd.; Eli Lilly and Company; Galderma SA; GlaxoSmithKline PLC; Glenmark Pharmaceuticals Ltd.; Ipca Laboratories Ltd.; Lupin Ltd.; Merck & Co., Inc.; Novartis AG; Pfizer, Inc.; Sanofi SA; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Co., Ltd.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Pruritus Therapeutics – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 38 Players Worldwide in 2024 (E)

Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Skin Disorders Propels Market Growth

Increasing Awareness of Pruritus and Its Impact Expands Addressable Market Opportunity

Technological Advancements in Dermatological Treatments Strengthen Market Position

Surge in Demand for Effective Itch Management Solutions Generates New Opportunities

Development of Novel Anti-Pruritic Drugs Sustains Market Growth

Expanding Applications in Chronic and Systemic Conditions Throws Spotlight on Market Potential

Growth in Geriatric Population Spurs Demand for Pruritus Therapeutics

Rising Adoption of Biologic Therapies for Severe Pruritus Propels Market Expansion

Surge in Demand from Emerging Markets Expands Market Horizons

Innovations in Topical and Systemic Treatments Generate New Market Opportunities

Increasing Focus on Addressing Pruritus in Rare Diseases Accelerates Market Growth

4. GLOBAL MARKET PERSPECTIVE

World Pruritus Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Pruritus Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Pruritus Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Pruritus Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Antihistamines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Counterirritants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Counterirritants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Counterirritants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Immunosuppressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Local Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

JAPAN

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

CHINA

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

EUROPE

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Pruritus Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Pruritus Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

FRANCE

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

GERMANY

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

UNITED KINGDOM

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of World 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Bristol-Myers Squibb Company	%
DELTAMEDICA GmbH	%
Elorac	%
Mirum Pharmaceuticals, Inc.	%
Rishab Healthcare Pvt Ltd.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll